Sara Boyce, President & CEO, Avidity Biosciences

Sara Boyce, President & CEO, Avidity Biosciences

Sara Boyce, President & CEO, Avidity Biosciences

Sarah Boyce is the President and CEO of Avidity Biosciences. She has extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies to patients. Ms. Boyce held multiple executive-level roles at leading pharma and biotech companies including Akcea Therapeutics, Ionis Pharmaceuticals, Forest Laboratories, Alexion Pharmaceuticals, Novartis Oncology and Roche. Ms. Boyce currently serves as a member of the board of directors at Ligand, Inc and Berkeley Lights, Inc.